My Account Follow us on: 
										Powered By 
										






 See the top gainers, losers, invest and get updated what's happening in the crypto market Invest Now 
										Powered By 
										
















 India's Largest Regional Retail Option Traders Summit. (BOTS) is a prestigious options trading event organized by Traders Gurukul. Held on the 2nd OR 3rd Sunday of every month, across top cities in India Invest Now 
										Powered By 
										










 This functionality will provide users with ease of access navigation and enable create a new revenue line by generating leads of potential customers for brokers in a more integrated manner. Invest Now Nifty 50 24572.65 0.00 (0.00%) Sensex 80424.68 0.00 (0.00%) BSE: 524742 | NSE: CAPLIPOINT | 


Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ |
ISIN: INE475E01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs BSE Live Prev. Close 1585.75 Open Price 1615.25 Bid Price (Qty.)
                    1814.95 (6)
 1814.95 (6) Offer Price (Qty.)
                    1831.60 (11)
 1831.60 (11) NSE Live Prev. Close 1585.50 Open Price 1605.50 Bid Price (Qty.)
                    0.00 (0)
 0.00 (0) Offer Price (Qty.)
                    1845.95 (13455)
 1845.95 (13455) 

Aug 08, 2024 16:13 Source: BSE 

 
Aug 08, 2024 16:13 Source: BSE 
  Caplin Point Laboratories - Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement with respect to Financial Results in Financial Express (English Newspaper) and Maalai Malar (Tamil Newspaper) is attached. 

Aug 08, 2024 10:49 Source: BSE 

 
Aug 08, 2024 10:49 Source: BSE 
  Caplin Point Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release Attached the Press Release for Grant of USFDA Approval. 

Aug 07, 2024 20:52 Source: BSE 

 
Aug 07, 2024 20:52 Source: BSE 
  Caplin Point Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome The weblink for the Earnings call is enclosed herewith. 

Aug 07, 2024 13:15 Source: BSE 

 
Aug 07, 2024 13:15 Source: BSE 
  Caplin Point Laboratories - Corporate Action-Board approves Dividend The Board has recommended Final Dividend of INR 2.5 per equity shares subject to the approval of shareholders 

Aug 07, 2024 13:08 Source: BSE 

 
Aug 07, 2024 13:08 Source: BSE 
  Caplin Point Laboratories - Announcement under Regulation 30 (LODR)-Change in Directorate The details of re-appointment of Managing Director is attached herewith. 

Aug 07, 2024 13:05 Source: BSE 

 
Aug 07, 2024 13:05 Source: BSE 
  Caplin Point Laboratories - Financial Results For The Quarter Ended June 30, 2024 The financial results for the quarter ended June 30, 2024 and the other items are enclosed 

Aug 07, 2024 12:59 Source: BSE 

 
Aug 07, 2024 12:59 Source: BSE 
  Caplin Point Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Approval of financial results and other items as enclosed 

Jul 19, 2024 11:32 Source: NSE 

 
Jul 19, 2024 11:32 Source: NSE 
  Caplin Point Laboratories Limited Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated July 19, 2024, titled "Press Release for Grant of USFDA Approval 

Jul 19, 2024 10:45 Source: BSE 

 
Jul 19, 2024 10:45 Source: BSE 
  Caplin Point Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release - Grant of USFDA Approval 

Jul 16, 2024 16:45 Source: BSE 

 
Jul 16, 2024 16:45 Source: BSE 
  Caplin Point Laboratories - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS The details of allotment of equity shares on exercise of ESOPs is attached herewith.  Copyright Â© e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form 
        or medium without express writtern permission of moneycontrol.com is prohibited. You are already a Moneycontrol Pro user.